Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 16.75% is 21% above its 5-year average of 13.80%, near the high end of its 5-year range (6.17%–20.90%).
12.07% above its 12-month average of 14.95%.
Reported quarterly operating margin; no daily interpolation. Q4 FY2026 (2026-06-30): 17.30%.
OPERATING MARGIN
16.75%
OPERATING MARGIN AVG TTM
14.95%
OPERATING MARGIN AVG 3Y
16.08%
OPERATING MARGIN AVG 5Y
13.80%
OPERATING MARGIN AVG 10Y
14.10%
OPERATING MARGIN AVG 15Y
8.79%
OPERATING MARGIN AVG 20Y
7.64%
CURRENT VS TTM AVG
+12.07%
CURRENT VS 3Y AVG
+4.19%
CURRENT VS 5Y AVG
+21.41%
CURRENT VS 10Y AVG
+18.82%
CURRENT VS 15Y AVG
+90.64%
CURRENT VS 20Y AVG
+119.15%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Pro-Dex, Inc.
Market Cap
$207.27M
Operating Margin
16.75%
TTM Avg
14.95%
3Y Avg
16.08%
5Y Avg
13.80%
Market Cap
$208.31M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$205.80M
Operating Margin
-1601.12%
TTM Avg
-930.37%
3Y Avg
-642.01%
5Y Avg
-2085.93%
Market Cap
$209.91M
Operating Margin
40.94%
TTM Avg
-5.20%
3Y Avg
-130.22%
5Y Avg
-446.71%
Market Cap
$210.41M
Operating Margin
-613.66%
TTM Avg
-295.68%
3Y Avg
-148.45%
5Y Avg
-98.97%
Market Cap
$210.98M
Operating Margin
-566038.89%
TTM Avg
-577080.92%
3Y Avg
-336097.22%
5Y Avg
-224856.35%
Market Cap
$200.96M
Operating Margin
-692.83%
TTM Avg
-418.51%
3Y Avg
-274.13%
5Y Avg
-339.94%
Market Cap
$214.24M
Operating Margin
6.67%
TTM Avg
9.41%
3Y Avg
-3.44%
5Y Avg
-14.56%
Market Cap
$214.46M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pro-Dex, Inc. (PDEX) | $207.27M | 16.75% | 14.95% | 16.08% | 13.80% |
| Electra Therapeutics Inc. (ETRA)vs › | $208.31M | N/A | N/A | N/A | N/A |
| Whitehawk Therapeutics Inc (WHWK)vs › | $205.80M | -1601.12% | -930.37% | -642.01% | -2085.93% |
| Compugen Ltd. (CGEN)vs › | $209.91M | 40.94% | -5.20% | -130.22% | -446.71% |
| Entrada Therapeutics, Inc. (TRDA)vs › | $210.41M | -613.66% | -295.68% | -148.45% | -98.97% |
| Lyell Immunopharma, Inc. (LYEL)vs › | $210.98M | -566038.89% | -577080.92% | -336097.22% | -224856.35% |
| Alector, Inc. (ALEC)vs › | $200.96M | -692.83% | -418.51% | -274.13% | -339.94% |
| Niagen Bioscience Inc (NAGE)vs › | $214.24M | 6.67% | 9.41% | -3.44% | -14.56% |
| Sionna Therapeutics, Inc. (SION)vs › | $214.46M | 0.00% | 0.00% | 0.00% | 0.00% |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $215.07M | 66.70% | 45.54% | 40.90% | 43.81% |
Gross Margin
31.4%
Operating Margin
16.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 17.30% |
| 2026-03-31 | 15.51% |
| 2025-12-31 | 17.46% |
| 2025-09-30 | 16.78% |
| 2025-06-30 | 7.68% |
| 2025-03-31 | 20.90% |
| 2024-12-31 | 16.03% |
| 2024-09-30 | 20.23% |
| 2024-06-30 | 15.65% |
| 2024-03-31 | 15.48% |
| 2023-12-31 | 6.17% |
| 2023-09-30 | 15.35% |
| 2023-06-30 | 15.13% |
| 2023-03-31 | 15.79% |
| 2022-12-31 | 10.08% |
| 2022-09-30 | 8.57% |
| 2022-06-30 | 9.38% |
| 2022-03-31 | 11.02% |
| 2021-12-31 | 15.75% |
| 2021-09-30 | 13.20% |
| 2021-06-30 | 6.25% |
| 2021-03-31 | 15.89% |
| 2020-12-31 | 6.30% |
| 2020-09-30 | 18.03% |
| 2020-06-30 | 19.80% |
| 2020-03-31 | 20.03% |
| 2019-12-31 | 20.95% |
| 2019-09-30 | 20.59% |
| 2019-06-30 | 16.86% |
| 2019-03-31 | 13.09% |
| 2018-12-31 | 18.64% |
| 2018-09-30 | 24.99% |
| 2018-06-30 | 8.55% |
| 2018-03-31 | 11.50% |
| 2017-12-31 | 6.24% |
| 2017-09-30 | 16.70% |
| 2017-06-30 | 14.72% |
| 2017-03-31 | 20.37% |
| 2016-12-31 | 5.85% |
| 2016-09-30 | 5.41% |
| 2016-06-30 | 3.75% |
| 2016-03-31 | 0.94% |
| 2015-12-31 | 7.28% |
| 2015-09-30 | -2.90% |
| 2015-06-30 | 1.72% |
| 2015-03-31 | -9.94% |
| 2014-12-31 | -14.08% |
| 2014-09-30 | -7.28% |
| 2014-06-30 | -0.50% |
| 2014-03-31 | -18.22% |
| 2013-12-31 | -14.24% |
| 2013-09-30 | 0.82% |
| 2013-06-30 | -25.42% |
| 2013-03-31 | -25.20% |
| 2012-12-31 | -12.64% |
| 2012-09-30 | -1.50% |
| 2012-06-30 | -21.91% |
| 2012-03-31 | -14.81% |
| 2011-12-31 | -5.75% |
| 2011-09-30 | 7.58% |
| 2011-06-30 | 15.13% |
| 2011-03-31 | 14.86% |
| 2010-12-31 | 9.27% |
| 2010-09-30 | 6.95% |
| 2010-06-30 | -70.06% |
| 2010-03-31 | 6.64% |
| 2009-12-31 | 2.32% |
| 2009-09-30 | 4.21% |
| 2009-06-30 | 4.25% |
| 2009-03-31 | -36.20% |
| 2008-12-31 | 1.78% |
| 2008-09-30 | -2.76% |
| 2008-06-30 | -14.32% |
| 2008-03-31 | 2.73% |
| 2007-12-31 | 8.18% |
| 2007-09-30 | 8.68% |
| 2007-06-30 | 6.42% |
| 2007-03-31 | 5.93% |
| 2006-12-31 | -6.39% |
| 2006-09-30 | 8.16% |
| 2006-06-30 | 4.39% |
| 2006-03-31 | 0.19% |
| 2005-12-31 | 13.23% |
| 2005-09-30 | 10.84% |
| 2005-06-30 | 21.75% |
| 2005-03-31 | 10.52% |
| 2004-12-31 | 10.47% |
| 2004-09-30 | 20.95% |
| 2004-06-30 | 19.26% |
| 2004-03-31 | 12.11% |
| 2003-12-31 | 10.61% |
| 2003-09-30 | 9.50% |
| 2003-06-30 | 6.34% |
| 2003-03-31 | 3.44% |
| 2002-12-31 | -0.28% |
| 2002-09-30 | -0.07% |
